| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 116,650 | 150,995 | ||
| Restricted cash | 23,689 | 24,368 | ||
| Accounts receivable, net | 386,564 | 358,756 | ||
| Prepaid expenses and other current assets | 22,228 | 28,138 | ||
| Assets held for sale - current | 20,963 | - | ||
| Total current assets | 570,094 | 562,257 | ||
| Restricted cash | 2,665 | 2,607 | ||
| Investments and equity method investees | 8,936 | 8,978 | ||
| Property and equipment, net | 80,086 | 77,273 | ||
| Right-of-use assets - operating | 4,837 | 5,342 | ||
| Prepaid expenses and other noncurrent assets | 2,938 | 4,081 | ||
| Contract cost assets | 11,160 | 12,504 | ||
| Intangible assets, net | 623,693 | 651,169 | ||
| Goodwill | 1,075,376 | 1,137,321 | ||
| Assets held for sale - noncurrent | 73,674 | - | ||
| Total assets | 2,453,459 | 2,461,532 | ||
| Accounts payable | 72,180 | 69,460 | ||
| Accrued liabilities | 60,893 | 63,886 | ||
| Operating lease liability - current | 17,942 | 24,208 | ||
| Accrued compensation and employee benefits | 55,380 | 38,262 | ||
| Deferred revenue | 1,871 | 2,333 | ||
| Short-term debt, net | 5,118 | 172,119 | ||
| Reserve for claims and performance - based arrangements | 211,652 | 187,251 | ||
| Liabilities held for sale - current | 4,891 | - | ||
| Total current liabilities | 429,927 | 557,519 | ||
| Long-term debt, net | 1,054,822 | 648,455 | ||
| Other long-term liabilities | 3,784 | 3,787 | ||
| Tax receivables agreement liability | 108,105 | 108,105 | ||
| Operating lease liabilities - noncurrent | 4,433 | 8,411 | ||
| Deferred tax liabilities, net | 10,155 | 10,450 | ||
| Total liabilities | 1,611,226 | 1,336,727 | ||
| Class a common stock - 0.01 par value 750,000,000 shares authorized 117,564,460 and 116,575,773 shares issued, respectively | 1,176 | 1,175 | ||
| Additional paid-in-capital | 1,791,060 | 1,782,992 | ||
| Accumulated other comprehensive loss | -2,376 | -1,707 | ||
| Retained earnings (accumulated deficit) | -886,196 | -865,332 | ||
| Treasury stock, at cost 5,971,712 and 1,537,582 shares issued, respectively | 61,431 | 21,123 | ||
| Total shareholders equity | 842,233 | 896,005 | ||
| Preferred class a common stock - 0.01 par value 50,000,000 shares authorized 175,000 issued, respectively | - | 228,800 | ||
| Total liabilities, mezzanine equity and shareholders equity | 2,453,459 | 2,461,532 | ||
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)